prnewswire.comContinuity Biosciences investiert in PinPrint, Inc., und expandiert in den Bereich der Verabreichung sthetischer und kosmetischer Wirkstoffeabout 1 hour ago
prnewswire.comUnravel Biosciences Announces Submission of RVL-001 Clinical Study Applications for Rett Syndrome and Pitt Hopkins Syndrome to Colombian Health Regulatory Authorityabout 2 hours ago
prnewswire.comAkita Biosciences Announces Grant from the Flu Lab to Study Profi Nasal Spray in U.S. Healthcare Workersabout 2 hours ago
prnewswire.comGreenLight Biosciences Announces Breakthrough in RNA Herbicide Development, Advancing More Sustainable Weed Controlabout 3 hours ago
prnewswire.comContinuity Biosciences Invests in PinPrint, Inc., Expanding into Aesthetic and Cosmetic Drug Deliveryabout 3 hours ago
prnewswire.comScaleReady Announces March Biosciences as Recipient of G-Rex Grant to Advance Manufacturing of Novel CAR-T Cell Therapyabout 4 hours ago
prnewswire.comTuHURA Biosciences and Kineta Present Updated Results from Kineta's Phase I-II Study of KVA12123 and TuHURA's Mechanism of IFx-Hu2.0 Responses After Anti-PD-1 Therapy Failure in Advanced Melanoma at the American Association for Cancer Research Annual Meeting1 day ago
prnewswire.comNona Biosciences' Partner Pfizer Presents Preclinical Data on TOP1i-Based ADC Targeting MSLN at AACR Annual Meeting 20251 day ago
prnewswire.comKeymed Biosciences gibt die IND-Genehmigung fr CM518D1 durch die National Medical Products Administration of China zur Behandlung von Solide Tumoren bekannt2 days ago
prnewswire.comIDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)4 days ago
CashuLisata Therapeutics and Keymed's Innovations in Antibody-Drug Conjugate Development for Cancer Treatmentabout 11 hours ago
CashuLisata Therapeutics: Keymed Biosciences Achieves IND Approval for Innovative Cancer Treatment1 day ago
CashuLisata Therapeutics: Araceli Biosciences Secures Funding for AI-Driven Drug Discovery Innovations2 days ago